Michael J. Korrer, Ph.D.
Affiliations: | 2013 | Microbiology and Molecular Genetics | Medical College of Wisconsin, Milwaukee, WI, United States |
Area:
Immunology, Cell Biology, OncologyGoogle:
"Michael Korrer"Parents
Sign in to add mentor| John Routes | grad student | 2013 | Medical College of Wisconsin | |
| (Immunogenicity, Tumorigenicity and Concomitant Tumor Immunity.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lang C, Roy S, Wang Y, et al. (2022) Efferocytosis drives myeloid NLRP3 dependent inflammasome signaling secretion of IL-1β to promote tumor growth. Frontiers in Immunology. 13: 993771 |
| van Montfoort N, Borst L, Korrer MJ, et al. (2018) NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines. Cell |
| Zeng Q, Fu J, Korrer M, et al. (2018) Caspase-1 from Human Myeloid Derived Suppressor Cells Can Promote T-cell independent Tumor Proliferation. Cancer Immunology Research |
| Gadkaree SK, Fu J, Sen R, et al. (2017) Induction of tumor regression by intratumoral STING agonists combined with anti-programmed death-L1 blocking antibody in a preclinical squamous cell carcinoma model. Head & Neck |
| Korrer MJ, Zhang Y, Routes JM. (2016) Correction: Possible Role of Arginase-1 in Concomitant Tumor Immunity. Plos One. 11: e0153122 |
| Korrer MJ, Routes JM. (2015) Adenovirus serotype 5 E1A expressing tumor cells elicit a tumor-specific CD8+ T cell response independent of NKG2D. Results in Immunology. 5: 1-5 |
| Korrer MJ, Routes JM. (2014) Possible role of arginase-1 in concomitant tumor immunity. Plos One. 9: e91370 |